RxDoctor Payments Data

Joseph Soufer

Internal Medicine · Waterbury, CTNPI 1699797290

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $1,385 of the $2,135 with a category attached, or 64.9%. Eli Lilly accounts for 83.9% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2019 at $1,791 and has fallen 98.0% since, to $35 in 2025.

$2,135in general payments, 2019–2025

Across 40 payments — averaging $53.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$2K
  • Novo Nordisk$309
  • Merck$35
$21,826,679in research payments, 2019–2025

Across 4,851 payments — averaging $4499.42 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$9.5M
  • Modernatx, Inc.$3.7M
  • Senseonics, Incorporated$1.1M
  • Novo Nordisk AS$1M
  • AstraZeneca$700K
  • Amgen$666K
  • plus $5.1M from 34 others

What the payments were for

  • Travel & lodging$1,38565%
  • Food & beverage$45922%
  • Education$29014%

General payments by program year

19
20
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Eli Lilly29$1,791
Novo Nordisk10$309
Merck1$35

How this compares

$2,135 in reported general payments places this provider in the 85th percentile of 2,067 internal medicine providers in Connecticut.

See all internal medicine providers in Connecticut →

Other internal medicine in Waterbury

See the full list for Connecticut →

Where these figures come from

Is this you, or does something look wrong? →